Table 2 Blood glucose control and evaluation form
Study | Hypoglycemic treatment | Glycemic control levels | Follow-up times | Operational style |
|---|---|---|---|---|
AIDA | Oral medication 196 (60.49%) Insulin 110 (33.95%) None 18 (5.56%) Unknown 4 (1.23%) | Under control | 3Â years | stent |
BELLO | Insulin 25 (33.78%) | Unknown | 3Â years | PTA vs. Stent |
BIONICS | Unknown | Unknown | 2Â years | Stent |
BIOSCIENCE | Oral medication 345 (71.0%) Insulin 160 (32.9%) Diet only 152 (31.3%) None 21 (4.3%) | Under control | 1Â year | Stent |
CIBELES | Unknown | Unknown | 9Â months | Stent |
ENDEAVOR IV | Oral medication 426 (89.31%) None 51 (10.69%) | Under control | 1Â year | Stent |
HORIZONS AMI | Oral medication 282 (52.9%) Insulin 145 (27.2%) Diet only 102 (19.1%) | Under control | 1Â year | Stent |
ICE | Unknown | Unknown | 1Â year | Stent |
IMAP | Unknown | Unknown | 6Â months | Stent |
ISAR-DESIRE 2 | Unknown | Unknown | 8Â months | Stent |
ISAR-TEST 4 | Oral medication 286 (51.1%) Unknown 274 (48.9%) | Unknown | 10Â years | Stent |
ISAR-TEST 5 | Oral medication 438 (50.3%) Insulin 288 (33.1%) Unknown 144 (16.6%) | Under control | 10Â years | Stent |
SIRIUS | Unknown | Unknown | 9Â months | Stent |
SIRTAX | Unknown | Unknown | 5Â years | Stent |
SORT OUT III | Unknown | Unknown | 1Â year | Stent |
SORT OUT IV | Unknown | Unknown | 18Â months | Stent |
SORT OUT VIII | Oral medication 264 (51.6%) Insulin 166 (32.4%) Diet only 34 (6.6%) | Under control | 1Â year | Stent |
TAXUS IV | Insulin 105 (33%) Unknown 213 | Unknown | 6Â months | Stent |
TOSCA | Unknown | Unknown | 6Â months | PTA vs. Stent |
ZEST | Insulin 101 (13.3%) Unknown 659 | Unknown | Â | Stent |